UnitedHealth Group’s $3.29 billion takeover of Amedisys will undergo an in-depth antitrust review by the Department of Justice, according to a filing from Amedisys. The home-health company disclosed in a regulatory filing that it received a so-called second request seeking additional information on the deal from the antitrust agency on Aug. 4, Bloomberg reports. Read more.
Related Posts
Exclusive: Is Patient Loyalty a Thing of the Past?
A survey reveals that nearly 80% of patients will overwhelmingly change their medical provider if another offers simpler methods of communication.
November 23, 2022
Cigna Secures Restraining Order, Barring Executive From Joining CVS
In the order, the judge said Cigna “would suffer irreparable harm absent a temporary injunction” and that it was “inevitable” Bricker would share or use Cigna’s trade secrets while at CVS.
February 23, 2023
PA Lawmakers go After UPMC
The American Economic Liberties Project, a nonpartisan organization established in 2020, published an 18-page report on the nonprofit health system, titled "Critical Condition: How UPMC's Monopoly Power Harms Workers and Patients."
January 20, 2023
Prisma Health Files for Temporary Restraining Order Against UnitedHealthcare Amid Contract Dispute
In an Aug. 23 filing in South Carolina's 13th judicial court, Prisma Health alleged UnitedHealthcare disclosed information about Prisma Health's rate proposals to several media outlets, in violation of the two parties' contract agreement.
August 30, 2023